Hepatitis B vaccineis increasingly a routine childhoodvaccinationin many countries and is part of the WHO GAVI recommendations for highly endemic countries. The three-dose series can be started immediately at birth, with a schedule of 0, 1, and 6 months. Alternatively, doses can be given at ...
Mcauliffe, V. J.,Purcell, R H., AndGerin, J. L., Type B hepatitis: A review of current prospects for a safe and effective vaccine,Rev. Infect. Dis.2: 470–492 (1980). ArticlePubMedCASGoogle Scholar Melnick, J. L., Hepatitis B virus and liver cancer, in:Viruses Associated with ...
For example, there can be mentioned an adjuvant vaccine containing an antigen derived from a serum of a patient having NANB hepatitis who has a symptom of a jaundice, which serum exhibits high GPT activity (Japanese Patent Application Laid-Open Specification No. 59-42455); an NANBV antigen ...
Quality control of Hepatitis A vaccines is based on WHO's recommendations [3], the European Pharmacopoeia monograph [4] and the guideline for batch release [5]. Vaccine potency can be determined by an in vivo test comparing the amount of vaccine necessary to induce specific antibodies in mice...